有组织与机会性巴氏涂片检查对年轻女性宫颈癌风险的影响——芬兰一项病例对照研究
该芬兰病例对照研究纳入2004-2009年诊断且检测时年龄低于40岁的284例宫颈癌病例及1698例年龄匹配对照,评估有组织筛查与机会性检测与宫颈癌风险的关联。结果显示25岁以下女性任何巴氏涂片检查的OR为1.25(95%CI 0.46-3.43);25-39岁仅参加有组织筛查OR为0.52(0.36-0.77),仅机会性检测OR为0.86(0.60-1.25),两者均参加OR为0.48(0.29-0.79)。作者认为机会性检测未见明确的额外预防获益,研究也支持年轻年龄组筛查效果较小的发现。
要点
- 25岁以下女性诊断前0.5-5.5年内任何巴氏涂片检查与宫颈癌风险的OR为1.25(95%CI 0.46-3.43)。
- 25-39岁仅参加有组织筛查者OR为0.52(0.36-0.77),仅机会性检测者OR为0.86(0.60-1.25)。
- 25-39岁同时参加有组织筛查与机会性检测者OR为0.48(0.29-0.79)。
核心结论
- 机会性检测对预防宫颈癌未见明确的额外获益。
- 该研究也支持年轻年龄组筛查效果较小的发现。
研究设计与样本
- 芬兰癌症登记处2004-2009年诊断且检测时年龄低于40岁的284例宫颈癌病例,配以1698例年龄匹配对照。
- 筛查史与机会性检测数据来自大规模筛查登记处和芬兰国家卫生与福利研究所1997年以来的数据库。
- 采用非条件logistic回归估计参加有组织筛查和机会性检测与宫颈癌诊断关联的OR及95%CI,结果对自我选择偏倚和参加率进行了校正。
主要发现
- 25岁以下女性诊断前0.5-5.5年内任何巴氏涂片检查的宫颈癌OR为1.25(95%CI 0.46-3.43)。
- 25-39岁仅参加有组织筛查者OR为0.52(95%CI 0.36-0.77),仅参加机会性检测者OR为0.86(95%CI 0.60-1.25),两者均参加者OR为0.48(95%CI 0.29-0.79)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Effectiveness of organized cervical cancer screening has been shown in several studies. However, screening among women aged <25years has been suggested to have little or no impact on the risk of cervical cancer. Also the significance of opportunistic testing in preventing cervical cancer is unclear. The aim of this study was to clarify the effect of opportunistic testing and organized screening on the risk of cervical cancer among young Finnish women. METHODS: In the Finnish Cancer Registry there were 284 cervical cancer cases diagnosed and tested below the age of 40 in 2004-2009. Screening histories and data on opportunistic testing for these women and their 1698 age-matched controls were derived from databases of the Mass Screening Registry and The National Institute for Health and Welfare from 1997 onward. OR's and 95% CI's for the association of cervical cancer diagnosis and participation in organized screening and opportunistic testing were estimated using unconditional logistic regression. Results were corrected for self-selection bias and attendance rate. RESULTS: Among women aged under 25, OR of cervical cancer for any Pap test taken 0.5-5.5years before diagnosis was 1.25 (95% CI 0.46-3.43). Attending only organized screening at age 25-39 resulted in OR 0.52 (0.36-0.77), attending only opportunistic testing in OR 0.86 (0.60-1.25) and attending both in OR 0.48 (0.29-0.79). CONCLUSION: Opportunistic testing showed no clear additional benefit on preventing cervical cancer. The study also supports findings on a smaller effect of screening in younger age groups.
引用
- Makkonen P, Heinävaara S, Sarkeala T, et al. Impact of organized and opportunistic Pap testing on the risk of cervical cancer in young women - A case-control study from Finland. Gynecol Oncol. 2017. PMID: 28942994. doi:10.1016/j.ygyno.2017.09.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。